Test Background Both ethosuximide and sodium valproate are considered the drugs of choice with regard the control of simple absence seizures or petit mal seizures in epilepsy. Can usually be monitored clinically.
Clinical Indications Assessment of patient compliance Assessment of suspected toxicity
Reference Range See report
Sample Required SST (gold top), serum (red top) or heparin (green top)
Sample Volume 0.5 mL pre-dose trough sample
Turnaround Time Up to 6 weeks
Notes Not currently performed in house; this is a referred test.